[1]
Alzheimer’s Association Report. 2020 Alzheimer’s disease facts and figures. Alzheimers Dementia 2020; 16: 391-460.
[2]
World Health Organization. Dementia - Fact Sheet No 362, 2015. Available from: http://www.who.int/mediacentre/factsheets/fs362/en/
[3]
Lopez OL, DeKosky ST. Clinical symptoms of Alzheimer’s disease. Handb Clin Neurol 2008; 89: 207-16.
[4]
Reitz C. Alzheimer’s disease and the amyloid cascade hypothesis: a critical review Intl J Alzheimer’s Disease 2012; 2012369808
[5]
Kametani F, Hasegawa M. Reconsideration of amyloid hypothesis and tau hypothesis in Alzheimer’s disease. Frontiers Neurosci 2018; 12: 25.
[6]
Liu PP, Xie Y, Meng XY, Kang JS. History and progress of hypotheses and clinical trials for Alzheimer’s disease. Signal Transduct Target Ther 2019; 4: 1-22.
[7]
Yegla B, Parikh V. Rejuvenating procholinergic treatments for cognition enhancement in AD: current challenges and future prospects. Frontiers Syst Neurosci 2015; 8: 254.
[8]
Mitra S, Behabahani H, Eriksdotter M. Innovative therapy for Alzheimer’s disease with focus on biodelivery of NGF. Frontiers Neurosci 2019; 13: 38.
[9]
Maiese K. Forkhead transcription factors: new considerations for Alzheimer’s disease and dementia. J Translational Sci 2016; 2: 241-7.